Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-25

Clinical Trial Update: FGF19 and the Expression of IRS-1 and GLUT-1 in Gestational Diabetes Mellitus

View source ↗

Summary

A completed clinical trial investigating FGF19 and the expression of IRS-1 and GLUT-1 in Gestational Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FGF19 (FGF19)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Gestational Diabetes Mellitus | Status: COMPLETED